title: Alveolar macrophage kinetics and multinucleated giant cell formation after lung injury.
abstract: Multinucleated giant cells (MGC) are a prominent feature of some chronic inflammatory states in the lung. These cells are formed by macrophage fusion, but how this process relates to the kinetics of alveolar macrophage (AM) production and proliferation is not clear. In this serial study, we compare AM kinetics and MGC formation after instilling carbon, silica, asbestos, bleomycin, and saline into the lungs of mice. Animals were killed up to 16 weeks later with [3H]thymidine injected 1 h before death. Counts of AM and MGC were carried out after bronchoalveolar lavage, and cell labeling was assessed by autoradiography. All test substances induced an inflammatory response with equal AM numbers recovered up to 2 weeks. Subsequently, the number returned to normal after carbon but remained elevated in the other groups. After carbon the lung structure was normal, there was no increase in AM label, and no MGC formed. Bleomycin-injected lungs progressed to fibrosis with only a brief, small increase in AM labeling and no MGC formation. After silica, and particularly asbestos, the lungs showed fibrosis, and many granulomas with large MGC were seen. Lavaged AM from these lungs showed a significant increase in DNA synthesis after 2 weeks, followed by higher numbers of MGC, none of which were labeled. Labeled AM tended to be free of particles, whereas MGC after 4 weeks contained many particles. The results indicate a relationship between AM proliferation and fusion, whereby AM growth appears to be prerequisite for cell infusion and MGC formation as a feature of granulomatous disease.
authors.affiliation: Department of Pathology, University of Manitoba, Winnipeg, Canada.
authors.forename: H
authors.initials: H
authors.lastname: Prieditis
authors.forename: I Y
authors.initials: IY
authors.lastname: Adamson
mesh_terms: D000818:Animals; D001194:Asbestos / Q000633:toxicity; D001345:Autoradiography; D001761:Bleomycin / Q000633:toxicity; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D002244:Carbon / Q000494:pharmacology; D002452:Cell Count; D002453:Cell Cycle / Q000502:physiology; D005355:Fibrosis; D015726:Giant Cells / Q000166:cytology* / Q000187:drug effects; D008168:Lung / Q000187:drug effects / Q000473:pathology; D017563:Lung Diseases, Interstitial / Q000139:chemically induced / Q000473:pathology; D008262:Macrophage Activation / Q000502:physiology; D016676:Macrophages, Alveolar / Q000166:cytology* / Q000187:drug effects; D008297:Male; D051379:Mice; D011014:Pneumonia / Q000139:chemically induced / Q000150:complications / Q000473:pathology*; D012822:Silicon Dioxide / Q000633:toxicity
chemical_list: D001761:Bleomycin; D001194:Asbestos; D002244:Carbon; D012822:Silicon Dioxide